From: Derivation and validation of a lipid-covered prognostic model for mature T-cell lymphomas
Basic results | Univariate analysis | Multivariate analysis | ||||||
---|---|---|---|---|---|---|---|---|
B | SE | HR (95% CI) | P-value | B | SE | HR (95% CI) | P-value | |
Age, ≥ 60 vs. < 60, years | 0.937 | 0.248 | 2.553 (1.570, 4.151) | 0.000 |  |  |  |  |
Sex, male vs. female | − 0.039 | 0.267 | 0.961 (0.569, 1.623) | 0.883 |  |  |  |  |
ECOG score, ≥ 2 vs. < 2 | 1.311 | 0.259 | 3.710 (2.232, 6.167) | 0.000 |  |  |  |  |
BM involvement, presence vs. absence | 0.988 | 0.261 | 2.687 (1.612, 4.480) | 0.000 | Â | Â | Â | Â |
Extranodal sites, ≥ 2 vs. < 2 | 1.991 | 0.293 | 7.326 (4.125, 13.010) | 0.000 | 0.892 | 0.424 | 2.439 (1.062, 5.602) | 0.036 |
Ann Arbor stage, III/IV vs. I/II | 1.209 | 0.296 | 3.350 (1.874, 5.988) | 0.000 | Â | Â | Â | Â |
B symptoms, presence vs. absence | 0.446 | 0.264 | 1.563 (0.931, 2.623) | 0.091 | Â | Â | Â | Â |
LDH, ≥ 250 vs. < 250, U/L | 1.305 | 0.256 | 3.687 (2.231, 6.090) | 0.000 |  |  |  |  |
β2-MG, ≥ 3 vs. < 3, mg/L | 2.635 | 0.364 | 13.939 (6.835, 28.425) | 0.000 | 1.427 | 0.480 | 4.165 (1.625, 10.674) | 0.003 |
TC, ≤ 3.58 vs. > 3.58, mmol/L | 2.029 | 0.267 | 7.604 (4.507, 12.831) | 0.000 | 1.205 | 0.335 | 3.338 (1.732, 6.434) | 0.000 |
HDL-C, ≤ 0.95 vs. > 0.95, mmol/L | 0.860 | 0.246 | 2.364 (1.460, 3.828) | 0.000 |  |  |  |  |
TG, > 1.42 vs. ≤ 1.42, mmol/L | 0.880 | 0.248 | 2.412 (1.483, 3.922) | 0.000 |  |  |  |  |
IPI 4/5 vs. 3 vs. 2 vs. 0/1 | 0.770 | 0.110 | 2.160 (1.740, 2.682) | 0.000 | Â | Â | Â | Â |